Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Treatment of HIV-associated nephropathy
Jonathan A. Winston
, Godfrey C. Burns
, Paul E. Klotman
Icahn School of Medicine at Mount Sinai
Medicine
Medicine - Nephrology
Research output
:
Contribution to journal
›
Review article
›
peer-review
24
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Treatment of HIV-associated nephropathy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
HIV-associated Nephropathy (HIVAN)
100%
Highly Active Antiretroviral Therapy (HAART)
60%
End-stage Renal Disease
40%
Kidney Function
40%
Angiotensin-converting Enzyme Inhibitor (ACEi)
40%
Kidney Disease
20%
Most Common Cause
20%
Randomized Controlled Trial
20%
HIV Patients
20%
Long-term Benefit
20%
People of Color
20%
Chronic Renal Disease
20%
AIDS-defining Illness
20%
Short-term Benefits
20%
Nursing and Health Professions
HIV Associated Nephropathy
100%
Highly Active Antiretroviral Therapy
60%
End Stage Renal Disease
40%
Dipeptidyl Carboxypeptidase Inhibitor
40%
Human Immunodeficiency Virus
20%
Chronic Kidney Failure
20%
Kidney Disease
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
HIV Associated Nephropathy
100%
End Stage Renal Disease
40%
Dipeptidyl Carboxypeptidase Inhibitor
40%
HIV
20%
Kidney Disease
20%
Chronic Kidney Failure
20%
Randomized Controlled Trial
20%
Diseases
20%